Forecast Delay in a USD Cash Flow Hedge
Ardent Components, a EUR-functional industrial supplier, sells to a single US distributor. Treasury policy requires hedging 80% of highly probable USD forecast sales for the next 12 months. In March the group documented a cash flow hedge under IFRS 9: USD 38.4 million of forward sales against a forecast of USD 48 million, at an average contract rate of 1.0850. In June the distributor confirms that USD 12 million of the forecast orders will slip by about six months, into the following year and outside the current hedge horizon; delivery timing on the remainder is confirmed. Spot has moved to 1.0450. One forward with USD 8 million notional matures in 20 days and the treasurer must decide whether to deliver, roll, or close it. The CFO wants to know whether hedge accounting survives the delay, what hits the P&L this year, and whether the group should switch the remaining exposure to options ahead of an upcoming USD 20 million tender that may or may not be awarded.
1. Assess whether hedge accounting can continue for the delayed USD 12 million and state the accounting consequence if it cannot.
Read the worked answer
The test is whether the delayed cash flows remain highly probable and whether they still fall within the period designated in the documentation. A six-month slippage that the distributor has confirmed in writing is generally still highly probable - the transaction is expected to occur, just later - but it is no longer the designated forecast. The right response is a partial de-designation of USD 12m of the USD 38.4m notional (31.25%) and prospective re-designation of that portion into a new relationship whose documentation reflects the revised timing, supported by the distributor confirmation and updated cash flow forecast.
If management concludes the USD 12m is no longer highly probable (for example, the distributor will not commit to volumes), the relationship is discontinued for that portion and the related OCI balance is reclassified to P&L immediately. If it is still expected to occur, the OCI amount stays until the hedged cash flow affects profit - the accounting follows the cash flow, not the derivative's maturity.
Quantify what is at stake so the CFO can see it. On USD 12m, the forward was sold at 1.0850 against a market of 1.0450, an in-the-money position of roughly (1.0850 - 1.0450) x 12,000,000 = EUR 480,000 before forward points and discounting. That is the OCI balance that moves or stays depending on the judgement. Document the reassessment on the date it is made; a decision taken verbally at month-end and written up later will not withstand audit.
2. Recommend what to do with the USD 8 million forward maturing in 20 days, and quantify the position at current rates.
Read the worked answer
The contract is in the money: sold USD at 1.0850 while the market is 1.0450, a gain of about (1.0850 - 1.0450) x 8,000,000 = EUR 320,000, ignoring forward points and discounting.
Delivery only makes sense if a real USD receivable of USD 8m will settle around the maturity date. Check that first, because delivering without an underlying turns the contract into an unmatched speculative position and will not satisfy the hedge documentation.
If the receivable has slipped, two credible routes exist. Rolling the forward to the revised date keeps the hedge aligned with the cash flow and preserves hedge accounting, provided the documentation is updated and the critical terms (notional, currency, revised timing) still match the hedged item; the rollover cost is the forward points between the two dates, which should be compared against the alternative. Closing out realises the EUR 320k in cash but leaves the exposure open and raises the question of when the OCI gain is recycled - it must remain in OCI until the hedged cash flow occurs, provided it is still expected.
Recommendation: roll the portion that matches a confirmed future receivable, and close the balance. Do not deliver against a payment that has not been confirmed simply because the contract is profitable; a gain realised today on an exposure that no longer exists is a trading result dressed as a hedge. Record the rollover gain/loss separately so that effectiveness testing is not contaminated.
3. Advise on whether options are appropriate for the USD 20 million tender exposure, considering IFRS 9 and the economics.
Read the worked answer
Separate the economic question from the accounting one. Economically, a tender is a contingent exposure: if the group bids in USD and wins, it has USD revenue; if it loses, it has nothing. An option is the theoretically correct instrument because it protects the downside without obligating delivery if the tender fails.
The accounting answer is narrower. Hedge accounting for a forecast transaction requires the transaction to be highly probable. A tender that has not been awarded is usually only possible, not highly probable, so the option premium will generally run through P&L rather than OCI. That is a cost, but not a reason to leave a genuine commercial exposure unhedged - only a reason to size the premium deliberately.
A workable approach: hedge the portion of the tender pipeline whose award probability and margin can be supported (for example 50%, USD 10m), using an option or a participating forward, and treat the premium as an economic cost of the bid. At an indicative 2.0% premium on USD 10m, the cost is roughly EUR 190,000 - measurable against the tender margin, and much smaller than the loss from a 4% adverse move on USD 20m (about EUR 760,000 at current rates). Once the award is confirmed, replace the option with forwards and formally designate the resulting firm commitment. Keep the pre-award and post-award hedges in separate documentation so that a failed effectiveness test on one does not pull the other into P&L.